
ImpediMed
IPD.AXImpediMed Limited Price (IPD.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
2,021,740,728
(12.2972)%Description
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinar... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.0405-0.105
- Market Cap 85.08M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Devices
- ceo: Dr. Parmjot Bains M.D.
- IPO Date: October, 24, 2007
- Country: AU
- Currency: AUD
- Headquaters: Pinkenba, QLD
- Employees: 83
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
